BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course, 11 November 2024, Royal College of Physicians, London

This joint British Cardiovascular Society, British Cardio-Oncology Society and University College London Hospitals Cancer Academy course provides an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology. A multidisciplinary practical approach to common cardiac issues in oncology/haem-oncology patients will be explored. For the first time, dedicated sessions for oncologists and for haematologists will be incorporated into the day.

For further information and to register (£30 fee for pharmacists), click here

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course 2024 – BOPA

 

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article